Cargando…

TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors

With recent progress in understanding the pathogenesis of adrenocortical tumors (ACTs), identification of molecular markers to predict their prognosis has become possible. Transcription factor 21 (TCF21)/podocyte-expressed 1 (POD1) is a transcriptional regulatory protein expressed in mesenchymal cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passaia, Barbara dos Santos, Dias, Matheus Henrique, Kremer, Jean Lucas, Antonini, Sonir Roberto Rauber, de Almeida, Madson Queiroz, Fragoso, Maria Candida Barisson Villares, Lotfi, Claudimara Ferini Pacicco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827685/ https://www.ncbi.nlm.nih.gov/pubmed/29520253 http://dx.doi.org/10.3389/fendo.2018.00038

Ejemplares similares

POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells
por: França, Monica Malheiros, et al.
Publicado: (2015)

New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
por: França, Monica Malheiros, et al.
Publicado: (2017)

Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells
por: Kremer, Jean Lucas, et al.
Publicado: (2021)

SAT-147 Endogenous Expression of TCF21 by CRISPR/dCas9 System Results in Different Biological Responses in Adrenocortical Carcinoma and Hepatocarcinoma
por: Kremer, Jean Lucas, et al.
Publicado: (2020)

The human adrenal cortex: growth control and disorders
por: Lotfi, Claudimara Ferini Pacicco, et al.
Publicado: (2018)

ARMC5 mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules
por: da Conceição, Barbara Brito, et al.
Publicado: (2020)

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
por: Silveira, Elaine, et al.
Publicado: (2018)

Comparative Effect of ACTH and Related Peptides on Proliferation and Growth of Rat Adrenal Gland
por: Lotfi, Claudimara Ferini Pacicco, et al.
Publicado: (2016)

Amplification of the Insulin-Like Growth Factor 1 Receptor Gene Is a Rare Event in Adrenocortical Adenocarcinomas: Searching for Potential Mechanisms of Overexpression
por: Ribeiro, Tamaya Castro, et al.
Publicado: (2014)

The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia
por: Villares Fragoso, Maria Candida Barisson, et al.
Publicado: (2016)

Involvement of JAK-STAT-SOCS3 Pathway in the Regression of Mice X-Zone of Adrenal Cortex
por: Auricino, Thais Barabba, et al.
Publicado: (2021)

OR02-4 YAP1 Overexpression Associates With Worse Prognosis In Patients With Adrenal Tumors And YAP1 Inhibition By Verteporfin Reduces Tumorigenicity And Reverses Epithelial-mesenchymal Transition In Adrenocortical Tumor Cells
por: Bellido More, Candy, et al.
Publicado: (2019)

The Involvement of Nek2 and Notch in the Proliferation of Rat Adrenal Cortex Triggered by POMC-Derived Peptides
por: de Mendonca, Pedro Omori Ribeiro, et al.
Publicado: (2014)

SAT-178 Incidence, Patterns of Clinical Presentation, and Outcomes of Patients with Brain Metastasis Due to Adrenocortical Carcinoma
por: Amorim, Larissa Costa, et al.
Publicado: (2020)

SUN-180 A Case of Deoxycorticosterone-Producing Malignant Adrenocortical Tumor
por: Cartolano, Natasha Scaranello, et al.
Publicado: (2020)

Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis
por: Leal, Letícia F., et al.
Publicado: (2015)

SAT-165 Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

Correction: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis
por: Leal, Letícia F., et al.
Publicado: (2023)

Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors
por: de Paula Mariani, Beatriz Marinho, et al.
Publicado: (2012)

Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus
por: Costa, Marcia Helena Soares, et al.
Publicado: (2011)

Apoptosis regulation in adrenocortical carcinoma
por: Pereira, Sofia S, et al.
Publicado: (2019)

SAT-353 The Synthetic Vitamin D Analog EB1089 Restricts Adrenocortical Tumor Proliferation in NCI-H295 Xenograft Model
por: Bueno, Ana, et al.
Publicado: (2019)

An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH)
por: Charchar, Helaine Laiz Silva, et al.
Publicado: (2022)

POD-1/Tcf21 overexpression reduces endogenous SF-1 and StAR expression in rat adrenal cells
por: França, M. M., et al.
Publicado: (2015)

Role of the bHLH transcription factor TCF21 in development and tumorigenesis
por: Lotfi, C.F.P., et al.
Publicado: (2021)

SUN-218 Analysis of ATRX and ZNRF3 Expression and Copy Number Variation in a Pediatric and Adult Cohort with Adrenocortical Tumors
por: Brondani, Vânia Balderrama, et al.
Publicado: (2020)

Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma
por: Brondani, Vania Balderrama, et al.
Publicado: (2021)

SAT-LB34 Repressive Epigenetic Programs Reinforce Steroidogenic Differentiation and Wnt/β-Catenin Signaling in Aggressive Adrenocortical Carcinoma
por: Mohan, Dipika R, et al.
Publicado: (2020)

Resolution of Cyclicity After Pasireotide LAR in a Patient With Cushing Disease
por: Machado, Márcio Carlos, et al.
Publicado: (2021)

Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma
por: de Sousa, Gabriela Resende Vieira, et al.
Publicado: (2015)

FRI256 The Clinical Impacts Of Bi-allelic Germline Pathogenic Variant In TP53 In Two Patients With Li-Fraumeni Syndrome
por: Petry, Vanessa, et al.
Publicado: (2023)

A missense TCF1 mutation in a patient with mody‐3 and liver adenomatosis
por: Lerario, Antonio Marcondes, et al.
Publicado: (2010)

Application of PLC and HMI in the CO(2) transcritical refrigeration experimental platform
por: Gao, Jianye, et al.
Publicado: (2022)

A New Cre Driver Mouse Line, Tcf21/Pod1-Cre, Targets Metanephric Mesenchyme
por: Maezawa, Yoshiro, et al.
Publicado: (2012)

High Prevalence of Alterations in DNA Mismatch Repair Genes of Lynch Syndrome in Pediatric Patients with Adrenocortical Tumors Carrying a Germline Mutation on TP53
por: Brondani, Vania Balderrama, et al.
Publicado: (2020)

Gonadotropin-dependent pubertal disorders are common in patients with virilizing adrenocortical tumors in childhood
por: Stecchini, Monica F, et al.
Publicado: (2019)

MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
por: Andrade, Natália Xavier S, et al.
Publicado: (2020)

Familial Adenomatous Polyposis Associated With Bilateral Adrenocortical Tumors and Agressive Desmoid Tumor
por: Neiva, Raíssa P, et al.
Publicado: (2021)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_135opvpans53780v8qrku25s1d